Literature DB >> 14989736

Unique cell membrane expression of topoisomerase-II alpha as a useful diagnostic marker of liposarcoma.

Hideko Endo1, Mitsuyoshi Hirokawa, Naozumi Ishimaru, Yasushi Tanaka, Michiko Yamashita, Mika Sakaki, Yoshio Hayashi, Toshiaki Sano.   

Abstract

Topoisomerase-II alpha (Topo-II alpha) is known as a cell cycle-related intranuclear marker. To the best of our knowledge, the expression of Topo-II alpha on extranuclear sites has not been reported. The aim of the present study was to determine the usefulness of Topo-II alpha immunostaining for detecting the lipoblasts that are essential to diagnosing liposarcoma. Surgical specimens, including benign lipomatous tumors (four cases), well-differentiated liposarcomas (three cases), myxoid liposarcomas (six cases), pleomorphic liposarcomas (two cases), dedifferentiated liposarcomas (two cases), myxoid malignant fibrous histiocytomas (six cases), and one case of mesenteric panniculitis, were studied. Samples were immunostained using antibodies for Topo-II alpha, S-100 protein and Ki-67. In addition, we used the western blot method to investigate immunohistochemical-affinity in adipocytes. Mature adipocytes and lipoblasts in all of the benign and malignant lipomatous tumors intensively expressed cell contours positivity for Topo-II alpha. Cytoplasm of the lipoblasts occasionally reacted to the antibody and highlighted intracytoplasmic small unilocular, multivacuolated, or bubble-like patterns. Western blot analysis confirmed a 70 kDa product reactive to Topo-II alpha in the cell membrane fragment of mature adipocytes. S-100 protein expressed adipocytes and lipoblasts, but the detection of lipoblasts was not as easy as in Topo-II alpha immunostaining. Immunoreactivity of Ki-67 was limited to the nuclei, and the nuclear labeling index of Ki-67 correlated with that of Topo-II alpha. The immunoreactivity of Topo-II alpha for lipoblasts was more sensitive and obvious than those of S-100 protein. Immunostaining using the antibody for Topo-II alpha seems to be useful in recognizing lipoblasts that have been overlooked in hematoxylin-eosin-stained preparations, and is a useful marker for diagnosing liposarcoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14989736     DOI: 10.1111/j.1440-1827.2003.01600.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  4 in total

Review 1.  Human topoisomerase II alpha as a prognostic biomarker in cancer chemotherapy.

Authors:  Yousaf Ali; Shafida Abd Hamid
Journal:  Tumour Biol       Date:  2015-10-20

2.  Identification of differential protein expression associated with development of unstable human carotid plaques.

Authors:  Mark Slevin; Abdul Baset Elasbali; Marta Miguel Turu; Jerzy Krupinski; Lina Badimon; John Gaffney
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

3.  Expression of E-cadherin, beta-catenin and topoisomerase IIalpha in leiomyosarcomas.

Authors:  Pinelopi N Gogou; Anna Batistatou; Emilios E Pakos; Nikiforos Apostolikas; Dimitrios Stefanou; Pericles G Tsekeris
Journal:  Clin Transl Oncol       Date:  2009-08       Impact factor: 3.405

4.  Clinicopathologic study of E-cadherin/beta-catenin complex, and topoisomerase-II in a series of 71 liposarcoma cases.

Authors:  Pinelopi Gogou; Emilios Pakos; Anna Batistatou; Ioannis Panelos; Evangelos Briasoulis; Dimitrios Stefanou; Nikoforos Apostolikas; Periclis Tsekeris
Journal:  World J Surg Oncol       Date:  2012-02-02       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.